Skip to main content
AI Market Summary
Loading market intelligence...

Oyster Point Pharma Inc (OYST) Stock Forecast 2025 - AI Price Prediction & Analysis


Oyster Point Pharma Inc (OYST) AI Stock Price Forecast & Investment Analysis

Oyster Point Pharma Inc Stock Price Chart and Technical Analysis

Loading Oyster Point Pharma Inc interactive price chart and technical analysis...

Oyster Point Pharma Inc (OYST) - Comprehensive Stock Analysis & Investment Research

Deep dive into Oyster Point Pharma Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Oyster Point Pharma Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Oyster Point Pharma Inc: Oyster Point Pharma Inc operates in the Professional, Scientific, and Technical Services sector, making it an emerging small-cap investment.

Oyster Point Pharma Inc (Stock Symbol: OYST) is a leading company in the Professional, Scientific, and Technical Services sector , specifically operating within the Research and Development in Biotechnology industry.

The organization employs approximately 62 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Oyster Point Pharma Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Oyster Point Pharma Inc: With $37M in annual revenue and -259.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $37 million generating a -259.7% net profit margin .

Market Capitalization: $300 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -114.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Oyster Point Pharma Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Oyster Point Pharma Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Oyster Point Pharma Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Oyster Point Pharma Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Oyster Point Pharma Inc: Market positioning analysis based on available financial and operational metrics.

Oyster Point Pharma Inc strategically competes in the highly dynamic Research and Development in Biotechnology marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 40.6% gross margin, indicating strong pricing power and operational efficiency.

Oyster Point Pharma Inc (OYST) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Oyster Point Pharma Inc stock analysis.

Loading Oyster Point Pharma Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Oyster Point Pharma Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Oyster Point Pharma Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Oyster Point Pharma Inc: With a P/E ratio of -1.79, the market sees the stock as potentially undervalued.

P/E Ratio -1.79x
P/B Ratio -13.50x
Market Cap $300M
EPS $-6.65
Book Value/Share $-0.83
Revenue/Share $1.15
FCF/Share $-2.10
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Oyster Point Pharma Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Oyster Point Pharma Inc: An ROE of -114.4% indicates room for improvement in shareholder value creation.

ROE -114.4%
ROA -71.7%
ROIC -76.6%
Gross Margin 40.6%
Operating Margin -426.6%
Net Margin -259.7%
EBT Margin -475.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Oyster Point Pharma Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Oyster Point Pharma Inc: A current ratio of 7.26 indicates strong liquidity.

Current Ratio 7.26x
Quick Ratio 6.48x
D/E Ratio 1.65x
Financial Leverage 3.16x
Interest Coverage -18.1x
Working Capital $185M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Oyster Point Pharma Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Oyster Point Pharma Inc: Free cash flow of $-124M indicates cash challenges that need attention.

Operating Cash Flow $-123M
Free Cash Flow $-124M
Capital Spending $-1M
FCF/Sales -454.3%
CapEx/Sales 4.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Oyster Point Pharma Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Oyster Point Pharma Inc: An asset turnover of 0.15x suggests room for improvement in asset utilization.

Asset Turnover 0.15x
Receivables Turnover 4.8x
Inventory Turnover 0.5x
Fixed Assets Turnover 7.5x
Days Sales Outstanding 77 days
Days Inventory 803 days
Payables Period 950 days
Cash Conversion Cycle -70 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Oyster Point Pharma Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Oyster Point Pharma Inc: With annual revenue of $37M, Oyster Point Pharma Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $37M
Operating Income $-158M
Net Income $-96M
R&D Expense $19M
SG&A Expense $449M
Cost of Goods Sold $-74M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 95%
Cash & Short-term Investments 81%
Total Liabilities 68%
Accounts Receivable 3%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 27M
Growth Metrics (YoY)
EPS Growth -59.5%

Latest Oyster Point Pharma Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Oyster Point Pharma Inc (OYST) stock price and investment outlook.

, source: Law

Lupin, an Indian pharmaceutical company, was hit with a patent infringement lawsuit on Nov. 21 in New Jersey District Court over its plans to market a generic version of Tyrvaya nasal spray for dry ...

Oyster Point Pharma Inc Competitors & Peer Analysis - Professional, Scientific, and Technical Services Sector

Comparative analysis of Oyster Point Pharma Inc against industry peers and competitors in the Professional, Scientific, and Technical Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Oyster Point Pharma Inc Stock Forecast

How accurate are Oyster Point Pharma Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for OYST predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Oyster Point Pharma Inc stock price forecasts?

Our analysis considers Oyster Point Pharma Inc's financial metrics, Professional, Scientific, and Technical Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Oyster Point Pharma Inc a good investment in 2025?

Based on our AI analysis, Oyster Point Pharma Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Oyster Point Pharma Inc forecasts updated?

Oyster Point Pharma Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Oyster Point Pharma Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Oyster Point Pharma Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...